Press release
Castle Biosciences’ Founder, President and CEO Derek Maetzold Named an EY Entrepreneur Of The Year® 2024 Gulf South Award Winner
Maetzold selected as a winner of Ernst & Young’s prestigious annual awards among 48 visionary finalists in the Gulf South region, encompassing Central and
About this update from Castle Biosciences, Inc.
[{"type":"text","content":"\nMaetzold selected as a winner of Ernst & Young’s prestigious annual awards among 48 visionary finalists in the Gulf South region, encompassing Central and South Texas, Louisiana and Mississippi\n\n\n FRIENDSWOOD, Texas--(BUSINESS WIRE)--\nCastle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its founder, president and chief executive officer, Derek Maetzold, has been named by Ernst & Young LLP (EY) as an Entrepreneur Of The Year® 2024 Gulf South Award winner. Now in its 38th year, Entrepreneur Of The Year is the preeminent competitive awards program that celebrates entrepreneurs and leaders of high-growth companies who disrupt markets, revolutionize sectors and have a transformational impact on lives.\n\n\n“I am deeply honored and humbled to have been selected as the recipient of this esteemed award among the many other game-changing entrepreneurs who are also striving to make a difference,” said Maetzold. “At Castle, success is not just about the bottom line. It is about making a meaningful impact in this world by keeping people first — the patients and clinicians we serve, our employees and our investors — and by relentlessly pursuing excellence and innovation in all that we do.”\n\n\nMaetzold was selected by an independent judging panel made up of previous award winners, leading CEOs and other business leaders. Candidates were evaluated based on their ability to create long-term value through entrepreneurial spirit, commitment to their purpose and the demonstration of growth and substantial impact, among other core contributions and attributes.\n\n\nMaetzold founded Castle Biosciences in 2008 in an effort to improve care for patients with rare cancers. This foundational premise — that all patients deserve access to innovative tests that harness their unique biology to help clinicians make more informed choices for their care — continues to infuse the Company’s mission, vision, values and culture. Since its inception, the Company has grown from three initial employees to more than 690 nationwide, with revenue of approximately $220 million in 2023.\n\n\nEntrepreneur Of The Year recognizes many different types of business leaders for their ingenuity, courage and entrepreneurial spirit. The program celebrates original founders who bootstrapped ...